Preliminary results Norwegian doxazosin surveillance study twelve-week experience study safety efficacy doxazosin control blood pressure general medical practice results concern first patients period Blood pressure treatment doxazosin mm Hg heart rate addition doxazosin total cholesterol levels triglyceride levels high-density lipoprotein cholesterol levels high-density lipoprotein total cholesterol ratio calculated risk coronary heart disease period Thirty-five percent patients side effect number patients severe adverse reactions small patients treatment adverse events dose doxazosin 